GAMCO Investors’s BioMarin Pharmaceuticals BMRN Stock Holding History

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q1	$743K	Hold	13,150	–	–	0.01%	677
2025 Q4	$782K	Hold	13,150	–	–	0.01%	702
2025 Q3	$712K	Buy	13,150 +5,150	+64%	+$295K	0.01%	725
2025 Q2	$440K	Sell	8,000 -290	-3%	-$17.1K	﹤0.01%	847
2025 Q1	$586K	Sell	8,290 -1,750	-17%	-$118K	0.01%	650
2024 Q4	$660K	Buy	10,040 +3,475	+53%	+$233K	0.01%	651
2024 Q3	$461K	Buy	6,565 +1,250	+24%	+$104K	﹤0.01%	706
2024 Q2	$438K	Buy	+5,315	New	+$442K	﹤0.01%	710
2024 Q1	–	Sell	-2,483	Closed	-$239K	–	861
2023 Q4	$239K	Sell	2,483 -231	-9%	-$20.4K	﹤0.01%	781
2023 Q3	$240K	Sell	2,714 -470	-15%	-$41.8K	﹤0.01%	779
2023 Q2	$276K	Sell	3,184 -360	-10%	-$33.9K	﹤0.01%	768
2023 Q1	$345K	Buy	3,544 +290	+9%	+$30.1K	﹤0.01%	739
2022 Q4	$337K	Sell	3,254 -243	-7%	-$22.8K	﹤0.01%	748
2022 Q3	$296K	Buy	3,497 +95	+3%	+$8.46K	﹤0.01%	755
2022 Q2	$282K	Sell	3,402 -660	-16%	-$52.5K	﹤0.01%	783
2022 Q1	$313K	Sell	4,062 -703	-15%	-$58.8K	﹤0.01%	802
2021 Q4	$421K	Sell	4,765 -5,653	-54%	-$466K	﹤0.01%	766
2021 Q3	$805K	Sell	10,418 -386	-4%	-$30.5K	0.01%	666
2021 Q2	$901K	Buy	10,804 +30	+0.3%	+$2.38K	0.01%	661
2021 Q1	$814K	Buy	10,774 +6,504	+152%	+$531K	0.01%	661
2020 Q4	$374K	Buy	+4,270	New	+$339K	﹤0.01%	769
2019 Q2	–	Sell	-2,300	Closed	-$204K	–	930
2019 Q1	$204K	Buy	+2,300	New	+$213K	﹤0.01%	810
2018 Q4	–	Sell	-2,300	Closed	-$223K	–	800
2018 Q3	$223K	Hold	2,300	–	–	﹤0.01%	792
2018 Q2	$217K	Sell	2,300 -300	-12%	-$26.3K	﹤0.01%	809
2018 Q1	$211K	Hold	2,600	–	–	﹤0.01%	792
2017 Q4	$232K	Buy	+2,600	New	+$226K	﹤0.01%	785